LAKEFRONT BIOTHER…
NLEURLAKEFRONT BIOTHERAPEUTICS NV (LSE:0JXZ) — Biotechnology: Pharmaceutical Preparations. Liczba giełd, na których notowane są akcje spółki: 3. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- glpg.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siedziba
- Mechelen, Belgium
- Prezes
- Henry O. Gosebruch
- Pracownicy
- 196
- Założona
- 1999
- Akcje w Obrocie
- 65.48 mln
- Free Float
- 23.72 mln
- Kapitalizacja Rynkowa
- 1.74 mld EUR
- Insiderzy
- 25.36%
- Inwestorzy Instytucjonalni
- 43.14%
- Branża (SIC)
- Pharmaceutical Preparations
- Forma Prawna
- R85P
- ISIN
- BE0003818359
- LEI
- 549300QKJ78IY0IOV655
- FCF
- −271 mln EUR
- Dług
- ?
- Zyski i FCF — za 12 miesięcy do 31.12.2025 roku (najnowszy raport firmy).
Opis
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Wiadomości w Tym Tygodniu
Komunikaty prasowe ze strony firmy dla inwestorów, aktualizowane codziennie. Linki prowadzą na stronę firmy. Nagłówki są w oryginalnym języku, jak na stronie internetowej firmy.
| 13.10.2026 | Acquisition of Own Shares |
| 08.10.2026 | Lakefront Receives Transparency Notification from Bank of America |
| 06.10.2026 | Acquisition of Own Shares |
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.09% | 717 158 | 2026-07-31 |
| VANGUARD TAX-MANAGED FUN… | 0.73% | 483 750 | 2026-06-30 |
| iShares Trust-iShares Co… | 0.49% | 320 356 | 2026-08-31 |
| iShares Trust-iShares Bi… | 0.47% | 308 673 | 2026-08-31 |
| College Retirement Equit… | 0.39% | 258 786 | 2026-06-30 |
| DFA INVESTMENT TRUST CO-… | 0.38% | 252 302 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.36% | 234 000 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.35% | 233 829 | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.3% | 197 825 | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.18% | 119 147 | 2026-07-31 |
| Old Mission Capital, LLC | 0.07% | 45 496 | 2025-06-30 |
